Raffi Ahmad-Affiliated Firm Acquires Cardiac Hospital, Diversifies Business
PT Satu Visi Putra Tbk (VISI), associated with Indonesian celebrities Raffi Ahmad and Nagita Slavina, has acquired a 72.91% stake in PT Hasna Medika Bakti Cirebon (HMBC), the operator of Hasna Medika Hospital in Cirebon, West Java. This acquisition marks a diversification into the healthcare sector.
Read up to 3 eligible full articles per Japan day (JST) for free
Create a free account to open up to 3 eligible full articles per Japan calendar day (JST). Headlines and summaries remain available across ASEAN 7.
Related articles
- Talent Dimas Beck Appointed Independent Commissioner, IDEA Shares Skyrocket
PT Idea Indonesia Akademi Tbk (IDEA) approved a reshuffle of its board and amendments to its articles of association at an extraordinary general meeting of shareholders. The appointment of talent Dimas Beck as a candidate for independent commissioner led to a 278% surge in the company's shares, highlighting how celebrity involvement can attract market attention.
- Indonesia Encourages Investment Expansion in Algeria, Agrees on Instant Noodle Factory Construction
The Indonesian Ambassador to Algeria is promoting investment expansion in the northern Algerian province of Relizane. The provincial governor has opened opportunities for Indonesian companies to build factories, with a specific agreement reached on the site for the construction of an Indomie instant noodle factory.
- Indo Tambangraya Megah Decides Interim Dividend of Rp 1,286 per Share
PT Indo Tambangraya Megah Tbk (ITMG) has decided on an interim dividend of Rp 1,286.83 per share, representing 70% of its net profit for the first half of the 2026 fiscal year, totaling US$74.2 million.
- Indonesia Pushes for Pharmaceutical Sovereignty at ITS Surabaya Event
Taruna Ikrar championed Indonesia's pharmaceutical sovereignty at a conference held at ITS Surabaya. This initiative appears to be part of a broader effort to bolster the nation's drug manufacturing independence and improve public access to medicines.